Namely, various studies based on immunohistochemistry demonstrated the expression of all SSTR1 to SSTR5 on primary NB and, specifically, the overexpression of SSTR2 in the majority of NBs, even in recurrent/refractory tumor disease.113, 114. Here, SSTR2 is linked to neoplasm.